R. G. Nogueira Et Al. , "High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study," NEUROCRITICAL CARE , vol.7, no.3, pp.194-202, 2007
Nogueira, R. G. Et Al. 2007. High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study. NEUROCRITICAL CARE , vol.7, no.3 , 194-202.
Nogueira, R. G., Bodock, M. J., Koroshetz, W. J., Topcuoglu, M. A., Carter, B. S., Ogilvy, C. S., ... Pryor, J. C.(2007). High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study. NEUROCRITICAL CARE , vol.7, no.3, 194-202.
Nogueira, Raul Et Al. "High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study," NEUROCRITICAL CARE , vol.7, no.3, 194-202, 2007
Nogueira, Raul G. Et Al. "High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study." NEUROCRITICAL CARE , vol.7, no.3, pp.194-202, 2007
Nogueira, R. G. Et Al. (2007) . "High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study." NEUROCRITICAL CARE , vol.7, no.3, pp.194-202.
@article{article, author={Raul G. Nogueira Et Al. }, title={High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study}, journal={NEUROCRITICAL CARE}, year=2007, pages={194-202} }